John E. (Jack) Bailey Jr., President and CEO at G1 Therapeutics, Inc. (GTHX), sold 7,662 shares at $2.51 ($19K) on 2024-07-05, disclosed to the SEC on 2024-07-08.
Open-market sale of $19k GTHX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GTHX | SELL | 2024-01-02 | $216K | — | Filing → |
| GTHX | SELL | 2023-07-07 | $7K | — | Filing → |
| GTHX | SELL | 2023-01-05 | $406K | — | Filing → |